Tabalumab ( DrugBank: Tabalumab )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	4
49	全身性エリテマトーデス	1

46. 悪性関節リウマチ

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2012-001618-40-PL (EUCTR)	04/01/2013	31/10/2012	Evaluation of the blood concentration of Tabalumabafter the administration of Tabalumabusing prefill ...	Pharmacokinetic Evaluations of TabalumabFollowing Subcutaneous Administration by Prefilled syringe o ...	Rheumatoid Arthritis MedDRA version: 14.1;Level: LLT;Classification code 10042952;Term: Systemic rhe ...	Product Name: tabalumab Product Code: LY2127399 Other descriptive name: TABALUMAB	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	180		United States;Czech Republic;Argentina;Poland;Russian Federation
2	EUCTR2012-001618-40-CZ (EUCTR)	05/11/2012	03/08/2012	Evaluation of the blood concentration of Tabalumabafter the administration of Tabalumabusing prefill ...	Pharmacokinetic Evaluations of TabalumabFollowing Subcutaneous Administration by Prefilled syringe o ...	Rheumatoid Arthritis MedDRA version: 14.1;Level: LLT;Classification code 10042952;Term: Systemic rhe ...	Product Name: tabalumab Product Code: LY2127399 Other descriptive name: TABALUMAB	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	180		United States;Czech Republic;Argentina;Poland;Russian Federation
3	NCT01676701 (ClinicalTrials.gov)	September 2012	29/8/2012	Evaluation of TabalumabUsing Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arth ...	Pharmacokinetic Evaluations of TabalumabFollowing Subcutaneous Administration by Prefilled Syringe o ...	Rheumatoid Arthritis	Drug: Tabalumab Auto-Injector;Drug: Tabalumab Prefilled Syringe	Eli Lilly and Company	NULL	Terminated	18 Years	N/A	All	8	Phase 3	United States;Argentina;Czechia;Poland;Puerto Rico;Russian Federation;Czech Republic
4	NCT01253226 (ClinicalTrials.gov)	September 2009	1/12/2010	A Study for Japanese Participants With Rheumatoid Arthritis (RA)	Multiple-Dose, Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmaco ...	Rheumatoid Arthritis	Drug: LY2127399 (Tabalumab);Drug: Placebo	Eli Lilly and Company	NULL	Completed	20 Years	75 Years	All	32	Phase 1	Japan

First Previous1Next Last

49. 全身性エリテマトーデス

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02041091 (ClinicalTrials.gov)	January 2014	17/1/2014	A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus	Pharmacokinetic Evaluations of TabalumabFollowing Subcutaneous Administration by Prefilled Syringe o ...	Lupus Erythematosus, Systemic	Drug: Tabalumab Auto-Injector;Drug: Tabalumab Prefilled Syringe	Eli Lilly and Company	NULL	Terminated	18 Years	N/A	All	226	Phase 3	United States;Korea, Republic of;Puerto Rico;Mexico

First Previous1Next Last

先頭へ